Evidence map›Paper›PMID 17443624›Full record

SynthesisThe Cochrane database of systematic reviews2007

Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease.

K S Rabindranath, J Adams, T Z Ali, A M MacLeod, L Vale, J Cody, S A Wallace, C Daly

Open access · bronzeAbstract readComparative StudyMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Cochrane database of systematic reviews, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Comparison of volume overload with cycler-assisted versus continuous ambulatory peritoneal dialysis.Clinical journal of the American Society of Nephrology : CJASN · 2009
    Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Peritoneal dialysis care during the COVID-19 pandemic, Thailand.Bulletin of the World Health Organization · 2022
    Article
  11. Article
  12. Article
  13. ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis · 2016
    Review
  14. Observational
  15. Article
  16. Manifold exchange: a delivery option in managing patients on peritoneal dialysis.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
    Article
  17. Cost-effectiveness analysis of the Spanish renal replacement therapy program.Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

K S RabindranathRoyal Berkshire Hospital, Renal Unit, London Rd, Reading, UK, RG1 5AN. ksrabi@yahoo.co.uk
J Adams
T Z Ali
A M MacLeod
L Vale
J Cody
S A Wallace
C Daly
University of Aberdeen · GBAberdeen Royal Infirmary · GBChurchill Hospital · GBRoyal Berkshire Hospital · GBWestern Infirmary · GB

Funding

Chief Scientist Office HERU1Chief Scientist Office HERU2Chief Scientist Office HSRU2
6 · The paper itself

Abstract

backgroundPeritoneal dialysis (PD) can be performed either manually as in continuous ambulatory peritoneal dialysis (CAPD) or using mechanical devices as in automated PD (APD). APD has been considered to have several advantages over CAPD such as reduced incidence of peritonitis, mechanical complications and greater psychosocial acceptability.

objectivesTo assess the comparative efficacy of CAPD and APD in patients who are dialysed for end-stage renal disease (ESRD). SEARCH STRATEGY: We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Renal Group's specialised register and CINAHL. Authors of included studies were contacted, reference lists of identified RCTs and relevant narrative reviews were screened. Date of most recent search: May 2006 SELECTION CRITERIA: RCTs comparing CAPD with APD in patients with ESRD. DATA COLLECTION AND ANALYSIS: Data were abstracted independently by two authors onto a standard form. Relative risk (RR) for dichotomous data and a mean difference (MD) for continuous data were calculated with 95% confidence intervals (CI). MAIN

resultsThree trials (139 patients) were included. APD did not differ from CAPD with respect to mortality (RR 1.49, 95% CI 0.51 to 4.37), risk of peritonitis (RR 0.75, 95% CI 0.50 to 1.11), switching from original PD modality to a different dialysis modality (RR 0.50, 95% CI 0.25 to 1.02), hernias (RR 1.26, 95% interval 0.32 to 5.01), PD fluid leaks (RR 1.06, 95% CI 0.11 to 9.83), PD catheter removal (RR 0.64, 95% CI 0.27 to 1.48) or hospital admissions (RR 0.96, 95% CI 0.43 to 2.17). There was no difference between either PD modality with respect to residual renal function (MD -0.17, 95% CI -1.66 to 1.32). One study found that peritonitis rates and hospitalisation were significantly less in patients on APD when results were expressed as episodes/patient-year. Another study found that patients on APD had significantly more time for work, family and social activities. AUTHORS'

conclusionsAPD has not been shown to have significant advantages over CAPD in terms of important clinical outcomes. APD may however be considered advantageous in select group of patients such as in the younger PD population and those in employment or education due to its psychosocial advantages. There is a need for a RCT comparing CAPD with APD with sufficiently large patient numbers looking at important clinical outcomes including residual renal function, accompanied by an economic evaluation to clarify the relative clinical and cost-effectiveness of both modalities.

Indexed as

HumansKidney Failure, ChronicPeritoneal DialysisPeritoneal Dialysis, Continuous AmbulatoryRandomized Controlled Trials as Topic

Identifiers

PMID17443624
PMCPMC6669246
OpenAlexW1952979148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.